<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02199366</url>
  </required_header>
  <id_info>
    <org_study_id>UFPTI 1419-BR02</org_study_id>
    <secondary_id>IRB201800163</secondary_id>
    <secondary_id>UFJ 2014-116</secondary_id>
    <nct_id>NCT02199366</nct_id>
  </id_info>
  <brief_title>Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy</brief_title>
  <official_title>Prospective Pilot Study of Early Markers of Radiation-Induced Cardiac Injury in Patients With Left-Sided Breast Cancer Receiving Photon or Proton Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ocala Royal Dames</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to determine if there are changes in heart function following&#xD;
      completion of radiation therapy for breast cancer as measured by cardiac magnetic resonance&#xD;
      imaging (cardiac MRI) scans. Additional purposes of this study are to assess cardiac side&#xD;
      effects from radiation treatment, evaluate cardiac MRI changes by radiation technique, and&#xD;
      compare quality of life questionnaires.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As part of this study, participants will have a cardiac MRI at baseline and a follow-up&#xD;
      cardiac MRI within 1 year after completion of standard radiation therapy for left-sided&#xD;
      breast cancer. The cardiac MRI scans will be evaluated to determine if there are changes in&#xD;
      cardiac function within 1 year after radiation treatment.&#xD;
&#xD;
      Patients will be asked to complete a questionnaire before and after treatment that asks about&#xD;
      their health and any symptoms they may be having.&#xD;
&#xD;
      Physical exams and any other standard of care service or treatment will be at the discretion&#xD;
      of the treating physician.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 2014</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">July 7, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants with changes in cardiac function.</measure>
    <time_frame>1 year after completion of radiation therapy</time_frame>
    <description>A change in cardiac function may include shifts from baseline measures of LV mass, strain, ejection fraction, and late gadolinium enhancement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with serious cardiac side effects.</measure>
    <time_frame>1 year after completion of radiation therapy</time_frame>
    <description>Includes myocardial infarction, valve disorder, congestive heart failure, and angina.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean quality of life score.</measure>
    <time_frame>1 year after radiation treatment</time_frame>
    <description>Comparison of baseline and post treatment quality of life questionnaires completed by participants.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Cardiac magnetic resonance (cardiac MRI)</arm_group_label>
    <description>Participants will have a cardiac MRI at baseline and within 1 year after completion of radiation therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac magnetic resonance (cardiac MRI)</intervention_name>
    <description>Participants will have a cardiac MRI at baseline and within 1 year after completion of radiation therapy.</description>
    <arm_group_label>Cardiac magnetic resonance (cardiac MRI)</arm_group_label>
    <other_name>Cardiac MRI</other_name>
    <other_name>CMR</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Radiation oncology clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Left-sided breast cancer stage I-III.&#xD;
&#xD;
          -  Indications for adjuvant regional nodal and breast or chest wall radiation therapy&#xD;
             (RT).&#xD;
&#xD;
          -  Women and men are allowed.&#xD;
&#xD;
          -  Must be at least 18 years old at time of consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant and/or breastfeeding women or patients of child-producing potential not&#xD;
             willing to use contraception while on study.&#xD;
&#xD;
          -  Prior history of cardiovascular disease per physician discretion.&#xD;
&#xD;
          -  Stage 0 and IV breast cancer.&#xD;
&#xD;
          -  Prior radiation therapy to chest.&#xD;
&#xD;
          -  Concurrent trastuzumab per physician discretion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie A Bradley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida Proton Therapy Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Florida Proton Therapy Institute</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 22, 2014</study_first_submitted>
  <study_first_submitted_qc>July 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2014</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac MRI</keyword>
  <keyword>Radiation</keyword>
  <keyword>Proton Radiation</keyword>
  <keyword>Breast Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Unilateral Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

